Mark A. Kowieski's most recent trade in Evoke Pharma Inc was a trade of 4,500 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on March 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc | Mark A. Kowieski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.21 per share. | 20 Mar 2025 | 4,500 | 4,916 (0%) | 0% | 3.2 | 14,463 | Common Stock |
| Evoke Pharma Inc | Mark A. Kowieski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Evoke Pharma Inc | Mark A. Kowieski | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2024 | 17,291 | 17,291 | - | - | Stock Option (Right to Buy) |